These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study. El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
4. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors. Abo-Elmagd MI; Hassan RM; Aboutabl ME; Amin KM; El-Azzouny AA; Aboul-Enein MN Bioorg Chem; 2024 Sep; 150():107577. PubMed ID: 38941697 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
7. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study. Sakr A; Kothayer H; Ibrahim SM; Baraka MM; Rezq S Bioorg Chem; 2019 Mar; 84():76-86. PubMed ID: 30481648 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity. Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents. Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents. Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820 [TBL] [Abstract][Full Text] [Related]
11. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]
12. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity. Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895 [TBL] [Abstract][Full Text] [Related]
13. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621 [TBL] [Abstract][Full Text] [Related]
14. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study. El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117 [TBL] [Abstract][Full Text] [Related]
15. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study. El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993 [TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bakr RB; Ghoneim AA; Azouz AA Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742 [TBL] [Abstract][Full Text] [Related]
17. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme. El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives. Bakr RB; Azouz AA; Abdellatif KR J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]